Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1403.21x is 47% below its 5-year average of -953.76x, near the low end of its 5-year range (-1418.78x–-371.38x).
24.32% below its 12-month average of -1128.68x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -933.42x.
INTEREST COVERAGE RATIO
-1403.21x
INTEREST COVERAGE RATIO AVG TTM
-1128.68x
INTEREST COVERAGE RATIO AVG 3Y
-1039.17x
INTEREST COVERAGE RATIO AVG 5Y
-953.76x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-24.32%
CURRENT VS 3Y AVG
-35.03%
CURRENT VS 5Y AVG
-47.12%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 361 covered companies
CURRENT VS SECTOR MEDIAN
-32994.58%
vs the sector median at left
Kymera Therapeutics, Inc.
Market Cap
$8.49B
Interest Coverage Ratio
-1403.21x
TTM Avg
-1128.68x
3Y Avg
-1039.17x
5Y Avg
-953.76x
Market Cap
$8.54B
Interest Coverage Ratio
0.79x
TTM Avg
0.79x
3Y Avg
0.79x
5Y Avg
1.52x
Market Cap
$8.56B
Interest Coverage Ratio
1.10x
TTM Avg
1.10x
3Y Avg
1.10x
5Y Avg
1.10x
Market Cap
$8.39B
Interest Coverage Ratio
-22.52x
TTM Avg
2.41x
3Y Avg
2.41x
5Y Avg
2.41x
Market Cap
$8.83B
Interest Coverage Ratio
-25.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.10B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
Market Cap
$7.62B
Interest Coverage Ratio
-5.89x
TTM Avg
8.36x
3Y Avg
8.36x
5Y Avg
8.36x
Market Cap
$7.62B
Interest Coverage Ratio
5.64x
TTM Avg
4.71x
3Y Avg
3.13x
5Y Avg
2.65x
Market Cap
$9.36B
Interest Coverage Ratio
3.91x
TTM Avg
4.60x
3Y Avg
15.68x
5Y Avg
18.14x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | $8.49B | -1403.21x | -1128.68x | -1039.17x | -953.76x |
| Caris Life Sciences, Inc. (CAI)vs › | $8.54B | 0.79x | 0.79x | 0.79x | 1.52x |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.56B | 1.10x | 1.10x | 1.10x | 1.10x |
| Oscar Health, Inc. (OSCR)vs › | $8.39B | -22.52x | 2.41x | 2.41x | 2.41x |
| Axsome Therapeutics, Inc. (AXSM)vs › | $8.83B | -25.81x | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $9.10B | 3.91x | 4.60x | 15.68x | 18.14x |
| Cytokinetics, Incorporated (CYTK)vs › | $7.62B | -5.89x | 8.36x | 8.36x | 8.36x |
| HealthEquity, Inc. (HQY)vs › | $7.62B | 5.64x | 4.71x | 3.13x | 2.65x |
| Bruker Corporation (BRKR)vs › | $9.36B | 3.91x | 4.60x | 15.68x | 18.14x |
| Insulet Corp. (PODD)vs › | $9.37B | 5.94x | 6.59x | 5.07x | 3.90x |
Interest Coverage
-1403.2x
Debt/Equity
0.05
Current Ratio
9.83
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -933.42x |
| 2026-03-31 | -1379.57x |
| 2025-12-31 | -1418.78x |
| 2025-06-30 | -782.94x |
| 2025-03-31 | -1033.69x |
| 2024-12-31 | -1368.73x |
| 2024-09-30 | -1202.07x |
| 2024-06-30 | -834.84x |
| 2024-03-31 | -838.13x |
| 2023-12-31 | -371.38x |
| 2023-09-30 | -1402.66x |
| 2023-06-30 | -903.81x |
| 2023-03-31 | -824.11x |
| 2022-12-31 | -666.03x |
| 2022-09-30 | -1246.72x |
| 2022-06-30 | -995.37x |
| 2022-03-31 | -900.80x |
| 2021-12-31 | -679.88x |
| 2021-09-30 | -409.10x |
| 2021-06-30 | -883.21x |
| 2021-03-31 | -548.71x |
| 2020-12-31 | -473.41x |
| 2020-09-30 | -288.68x |
| 2020-06-30 | -567.68x |
| 2020-03-31 | -330.79x |
| 2019-12-31 | -392.77x |
| 2019-09-30 | -2965.25x |
